Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer
Jonathan Beesley1,2, Hilda Pickett3,4, Sharon Johnatty1, Xiaoqing Chen1, Jun Jun Li1, David Rider5, Michael Stutz3,4, Diether Lambrecht6,7, Jenny Chang-Claude8, Thilo Dork9, Marc Goodman10, Bart Kiemmney11,12,13, Elisa Bandera14, Linda Kelemen15, Shan Wang-Gorke7, Ian Campbell16, Simon Gayther17, Susan Ramus17, Ellen Goode5, Roger Reddel3,4, Georgia Chenevix-Trench1
1Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Australia
2Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany
3Cancer Research Unit, Children's Medical Research Institute, Westmead, Australia
4Sydney Medical School, University of Sydney, Sydney, Australia
5Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, USA
6Vesalius Research Center, VIB, Leuven, Belgium
7Vesalius Research Center, University of Leuven, Leuven, Belgium
8Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
9Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany
10Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, USA
11Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
12Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
13Comprehensive Cancer Center, The Netherlands, Nijmegen, The Netherlands
14The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, USA
15Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Canada
16Peter MacCallum Cancer Centre, East Melbourne, Australia
17Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, USA
Thông tin
Thông tin xuất bản
Springer Science and Business Media LLC
Tập 10
1-2
Thông tin tác giả